247 related articles for article (PubMed ID: 7978047)
1. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Monteleone PM; Andrzejewski C; Kelleher JF
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of transfusion-associated hepatitis C in a children's hospital.
Luban NL; Colvin CA; Mohan P; Alter HJ
Transfusion; 2007 Apr; 47(4):615-20. PubMed ID: 17381619
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E
West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339
[TBL] [Abstract][Full Text] [Related]
7. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
Matsuoka S; Tatara K; Hayabuchi Y; Taguchi Y; Mori K; Honda H; Itou S; Yuasa Y; Kuroda Y
Pediatrics; 1994 Dec; 94(6 Pt 1):919-22. PubMed ID: 7971011
[TBL] [Abstract][Full Text] [Related]
8. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
[TBL] [Abstract][Full Text] [Related]
10. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle cell anaemia in Enugu, South East Nigeria.
Ejiofor OS; Ibe BC; Emodi IJ; Ikefuna AN; Ilechukwu GC; Emechebe G; Ilechukwu C
Niger J Clin Pract; 2009 Dec; 12(4):355-8. PubMed ID: 20329670
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A
J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408
[TBL] [Abstract][Full Text] [Related]
12. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
Dubois F; Barin F; Goudeau A
Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C in patients with sickle cell disease.
Hasan MF; Marsh F; Posner G; Bellevue R; Dosik H; Suatengco R; Ramani N
Am J Gastroenterol; 1996 Jun; 91(6):1204-6. PubMed ID: 8651171
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
